Project Grant R01MH145192
Award Date 9/1/26
Completion Date 6/30/31
Dollars Obligated $726K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- The National Institute of Mental Health awarded the University of Alabama at Birmingham $678,550 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized clinical trial evaluating the Advanced HIV Re-engagement in Care (ARC) intervention in Zambia. ARC is a package of evidence-based, theory-informed elements delivered by supervised community health workers during hospitalization and the post-discharge period to improve outcomes for people with...
- The National Institute of Mental Health awarded the University of California, San Diego $793,814 on June 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate Recovery Integrated Safety and Engagement (RISE), a peer-supported suicide prevention intervention for individuals at clinical high risk for psychosis. The award funds a three-year hybrid Type 1 pilot study at two sites following the Exploration, Preparation, Implementation, Sustainment framework....
- The National Institute of Mental Health awarded the University of Alabama at Birmingham $786,444 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop an artificial intelligence-based decision support system for predicting and preventing return emergency department visits among mental health patients. The project will develop a large language model system to automatically extract mental health emergency department return risk factors from clinical notes,...
- The National Institute of Mental Health awarded Duke University $391,032 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to adapt a telehealth intervention for suicide prevention among patients with alcohol use disorder in Tanzania. The recipient will develop IDEAS-AUD, a telehealth intervention adapted from the evidence-based motivational interviewing intervention MI-SAFECOPE. The intervention addresses suicide risk through a four-pillared approach: reducing...
- The National Institute of Mental Health awarded the University of Pennsylvania $2.483 million on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish the Innovation in Suicide Prevention Research Center (INSPIRE), a research center focused on developing and scaling evidence-based suicide prevention interventions for youth and young adults. INSPIRE will develop and adapt practical suicide prevention interventions for youth and young adults and employ...
- The National Institute of Mental Health awarded the University of Alabama at Birmingham $2,590,839 on September 18, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate PROTECT AL, a dashboard and implementation framework designed to optimize HIV pre-exposure prophylaxis (PrEP) utilization across Alabama. The award funds a multi-phase mixed-methods implementation study that refines a performance measurement dashboard with clinic-level PrEP coverage...
- The National Institute of Mental Health awarded the University of Alabama at Birmingham $185,609 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct epidemiologic modeling identifying optimal evidence-based interventions to reduce HIV incidence in Alabama. The award funds mathematical modeling work embedded within a NIAID-funded R01 effectiveness-implementation trial evaluating three combination evidence-based interventions in the southwestern region of...
- The National Institute of Mental Health awarded Butler Hospital $781,566 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop RESTEPS, a suicide prevention intervention for youth with first-episode psychosis transitioning from acute care to outpatient treatment. The study addresses a critical gap: youth with first-episode psychosis face elevated suicide risk during care transitions, yet clinical trials of suicide-focused interventions routinely exclude...
- The National Institute of Mental Health awarded Rhode Island Hospital $855,638 on August 20, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a hybrid Type I trial examining the effectiveness of ED_REACH, a family navigation intervention for youth discharged from emergency departments following suicide or non-suicidal self-injurious behavior evaluations. The trial will test ED_REACH (Resilience, Education, and Caregiver Help) with youth and their caregivers,...
- The Substance Abuse and Mental Health Services Administration awarded $600,000 to the University of Illinois at Chicago on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532) to establish Project THRIVE, a trauma-informed workforce development initiative. Project THRIVE, led by the Urban Youth Trauma Center at UIC, will provide specialized training, consultation, and technical assistance to expand evidence-based,...